Gene · 7272
Papers3,094
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,094
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TTK/MPS1 inhibitor OSU-13 targets the mitotic checkpoint and is a potential therapeutic strategy for myeloma. | Haematologica | 2024 | 37496433 | PubTator, text mining | PubMed |
| Revisiting Szeptyckitheca Betsch & Weiner (Collembola, Symphypleona, Sminthuridae): new species, updated diagnoses, and a key. | Zookeys | 2023 | 38312858 | PubTator, text mining | PubMed |
| Progress in the treatment of lung adenocarcinoma by integrated traditional Chinese and Western medicine. | Front Med (Lausanne) | 2023 | 38259856 | PubTator, text mining | PubMed |
| Maximizing Anticancer Response with MPS1 and CENPE Inhibition Alongside Apoptosis Induction. | Pharmaceutics | 2023 | 38258067 | PubTator, text mining | PubMed |
| Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer. | Curr Oncol | 2023 | 38248100 | PubTator, text mining | PubMed |
| Cyclin A/Cdk1 promotes chromosome alignment and timely mitotic progression. | bioRxiv | 2023 | 38187612 | PubTator, text mining | PubMed |
| Artificial Intelligence-Based Patient Monitoring System for Medical Support. | Int Neurourol J | 2023 | 38171328 | PubTator, text mining | PubMed |
| Pharmacological approaches to understanding protein kinase signaling networks. | Front Pharmacol | 2023 | 38164473 | PubTator, text mining | PubMed |
| A Meta-Analysis of the Antidepressant Responses in Pivotal Trials on Esketamine Nasal Spray and Atypical Antipsychotics. | Neuropsychiatr Dis Treat | 2023 | 38161513 | PubTator, text mining | PubMed |
| Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma. | Front Immunol | 2023 | 38143740 | PubTator, text mining | PubMed |
| An Investigation of the Inverted Structure of a PBDB:T/PZT:C1-Based Polymer Solar Cell. | Polymers (Basel) | 2023 | 38139875 | PubTator, text mining | PubMed |
| Epigenomic Profiling Advises Therapeutic Potential of Leukotriene Receptor Inhibitors for a Subset of Triple-Negative Breast Tumors. | Int J Mol Sci | 2023 | 38139172 | PubTator, text mining | PubMed |
| C-Type Natriuretic Peptide Pre-Treatment Improves Maturation Rate of Goat Oocytes by Maintaining Transzonal Projections, Spindle Morphology, and Mitochondrial Function. | Animals (Basel) | 2023 | 38136917 | PubTator, text mining | PubMed |
| Editorial: Computational drug discovery of medicinal compounds for cancer management. | Front Chem | 2023 | 38130876 | PubTator, text mining | PubMed |
| Emerging evidence for dysregulated proteome cargoes of tau-propagating extracellular vesicles driven by familial mutations of tau and presenilin. | Extracell Vesicles Circ Nucl Acids | 2023 | 38125374 | PubTator, text mining | PubMed |
| Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor. | J Exp Clin Cancer Res | 2023 | 38124207 | PubTator, text mining | PubMed |
| A novel polymer enabled by polymerized small molecule strategy for tumor photothermal and photodynamic therapy. | J Nanobiotechnology | 2023 | 38124097 | PubTator, text mining | PubMed |
| The centrosomal protein 131 participates in the regulation of mitochondrial apoptosis. | Commun Biol | 2023 | 38102401 | PubTator, text mining | PubMed |
| Development of MPS1 Inhibitors: Recent Advances and Perspectives. | J Med Chem | 2023 | 38095579 | PubTator, text mining | PubMed |
| γδ T cell-mediated cytotoxicity against patient-derived healthy and cancer cervical organoids. | Front Immunol | 2023 | 38090581 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7272/papers?page=13